thyroid pharmacology
DESCRIPTION
Thyroid pharmacology. THYROID GLAND. Location 12 to 20 g in size In neck, anterior to trachea Between cricoid cartilage and suprasternal notch Highly vascular and soft in consistency. THYROID GLAND. Consists of two lobes Connected by an isthmus 4 parathyroid glands - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/1.jpg)
Thyroid pharmacology
![Page 2: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/2.jpg)
THYROID GLAND
Location
• 12 to 20 g in size
• In neck, anterior to trachea
• Between cricoid cartilage and suprasternal notch
• Highly vascular and soft in consistency.
![Page 3: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/3.jpg)
THYROID GLAND
Consists of two lobes
• Connected by an isthmus
• 4 parathyroid glands
– Posterior region of each pole
• Laryngeal nerves traverse lateral borders of gland
![Page 4: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/4.jpg)
Secretions
Produces two related hormones
• Thyroxine (T4)
• Triiodothyronine (T3)
![Page 5: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/5.jpg)
Action
Play a critical role in
• Cell differentiation during development
• Help to maintain thermogenic and metabolic homeostasis in adult.
• Act through nuclear hormone receptors to modulate gene expression
![Page 6: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/6.jpg)
Regulation of thyroid hormone synthesis
T4 and T3 feed back to inhibit
• Hypothalamic production of thyrotropin-releasing hormone (TRH)
• Pituitary production of thyroid-stimulating hormone (TSH)
![Page 7: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/7.jpg)
TSH-R, thyroid-stimulating hormone receptor, Tg- thyroglobulinNIS - sodium-iodide symporter; TPO- thyroid peroxidaseDIT - di-iodotyrosine; MIT - monoiodotyrosine
![Page 8: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/8.jpg)
Thyroid Hormone Synthesis
Thyroid hormones are derived from thyroglobulin• Large iodinated glycoprotein
After secretion into the thyroid follicle• Tg is iodinated on selected tyrosine residues that are
subsequently coupled via an ether linkage• Reuptake of Tg into thyroid follicular cell allows
proteolysis and the release of T4 and T3.
![Page 9: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/9.jpg)
Iodine Metabolism and Transport • Iodide uptake is a critical first step in thyroid
hormone synthesis
• Ingested iodine is bound to serum proteins (particularly albumin)
• Unbound iodine is excreted in urine
• Iodine extracts from circulation in a highly efficient manner– 10 to 25% of radioactive tracer (e.g., 123I) is taken up by
the normal thyroid gland over 24 h; this value can rise to 70 to 90% in Graves' disease.
![Page 10: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/10.jpg)
Na+/I- symporter (NIS)
• Mediate Iodide uptake • Expressed at basolateral membrane of thyroid
follicular cells.• Expressed
– Most highly in thyroid gland– Low levels in salivary glands, lactating breast, placenta
• Low I2 levels increase amount of NIS & stimulate uptake
• High I2 levels suppress NIS expression & uptake
![Page 11: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/11.jpg)
Selective expression of NIS in thyroid allows
– Treatment of hyperthyroidism– Isotopic scanning– Abolition of thyroid cancer with radioisotopes of iodine
Without significant effects on other organs
Mutation of the NIS gene is a rare cause of congenital hypothyroidism
![Page 12: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/12.jpg)
Oranification
• Iodide enters thyroid
• Trapped and transported to apical membrane of thyroid follicular cells
• Oxidized in an organification reaction (Tyroid PerOxidase & H2O2
)
![Page 13: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/13.jpg)
Coupling
Reactive iodine atom is added to selected tyrosyl residues within Tyroglobulin
Iodotyrosines in Tg are then coupled via an ether linkage in a reaction Catalyzed by TPO
Either T4 or T3 can be produced by this reaction• Depending on number of iodine atoms present in
iodotyrosines.
![Page 14: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/14.jpg)
Storage, Release• After coupling, Tg is taken back into thyroid cell
• It is processed in lysosomes to release T4 and T3
• Uncoupled mono- and diiodotyrosines (MIT, DIT) are deiodinated by enzyme dehalogenase
• Recycling any iodide that is not converted into thyroid hormones
![Page 15: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/15.jpg)
Factors Influence Synthesis and Release
TSH is the dominant hormonal regulator of thyroid gland growth and function
Variety of growth factors, most produced locally in thyroid gland, also influence synthesis
• Insulin-like growth factor I (IGF-I• Epidermal growth factor• Transforming growth factor β (TGF- β)• Endothelins• Various cytokines.
![Page 16: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/16.jpg)
• Disorders of thyroid hormone synthesis– Rare causes of congenital hypothyroidism
• Majority of disorders due to recessive mutations in TPO or Tg
• Defects also identified in– TSH-R– NIS– Pendrin anion transporter
• Transports I2 from cytoplasm to follicle lumen– H2O2 generation– Dehalogenase
![Page 17: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/17.jpg)
• Biosynthetic defect of thyroid hormone
• Inadequate amounts of hormone
• Increased TSH synthesis
• Goiter
![Page 18: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/18.jpg)
Transport And Metabolism
• T4 is secreted from the thyroid gland in at least 20-fold excess over T3
Both circulate bound to plasma proteins
• Thyroxine-binding globulin (TBG)
• Transthyretin (TTR), formerly known as thyroxine-binding prealbumin (TBPA)
• Albumin
![Page 19: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/19.jpg)
Functions of serum-binding proteins
• Increase pool of circulating hormone
• Delay hormone clearance
• Modulate hormone delivery to selected tissue sites
![Page 20: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/20.jpg)
Con. of TBG is relatively low (1 to 2 mg/dL)
• High affinity for thyroid hormones (T4 > T3), it carries about 80% of bound hormones
Albumin has relatively low affinity for thyroid hormones (high plasma con ~3.5 g/dL)
• It binds up to 10% of T4 and 30% of T3.
TTR carries about 10% of T4 but little T3.
![Page 21: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/21.jpg)
• ≈ 99.98% of T4 and 99.7% of T3 are protein-bound
• T3 is less tightly bound than T4
• Amount of free T3 > free T4
Unbound (free) cons
• T4 ~2 1011 M
• T3 ~6 1012 M
![Page 22: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/22.jpg)
![Page 23: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/23.jpg)
Deiodinases• In many respects, T4 may be thought of as a
precursor for more potent T3
• T4 is converted to T3 by the deiodinase enzymes
Type I deiodinase• Located primarily in thyroid, liver, kidney• Has a relatively low affinity for T4
Type II deiodinase• Higher affinity for T4 • Found primarily in pituitary gland, brain, brown fat,
thyroid gland
![Page 24: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/24.jpg)
![Page 25: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/25.jpg)
T4 - T3 conversion may be impaired by
• Fasting
• Acute trauma
• Oral contraseptive agents
• Propylthiouracil
• Propranolol
• Amiodarone
• Glucocorticoids
![Page 26: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/26.jpg)
THYROID HORMONE ACTION
• Act by binding to nuclear receptors, termed thyroid hormone receptors (TRs) ά and β
• Both ά and β are expressed in most tissues
• Both receptors are variably spliced to form unique isoforms
![Page 27: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/27.jpg)
Thyroid hormone receptors ά
Highly expressed in– Brain– Kidney– Gonads– Muscle– Heart
• TR ά 2 isoform contains a unique carboxy terminus that prevents thyroid hormone binding
• It may function to block actions of other TR isoforms
![Page 28: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/28.jpg)
Thyroid hormone receptors β
Highly expressed in– Pituitary– Liver
TR β 2 isoform• Has a unique amino terminus• Selectively expressed in hypothalamus & pituitary• Play a role in feedback control of thyroid axis
![Page 29: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/29.jpg)
(1) T4 or T3 enters the nucleus(2) T3 binding dissociates CoR from TR(3) Coactivators (CoA) are recruited to the T3-bound receptor(4) gene expression is altered
![Page 30: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/30.jpg)
Thyroid Hormone Resistance (RTH)
An autosomal dominant disorder characterized by
• Elevated free thyroid hormone levels• Inappropriately normal or elevated TSH
• Individuals with RTH (in general) do not exhibit signs and symptoms that are typical of hypothyroidism
• Apparently hormone resistance is compensated by increased levels of thyroid hormone
![Page 31: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/31.jpg)
HYPOTHYROIDISM
• Worldwide most common cause of hypothyroidism - Iodine deficiency
Other causes
• Autoimmune disease (Hashimoto's thyroiditis)
• Iatrogenic causes (treatment of hyperthyroidism)
![Page 32: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/32.jpg)
Treatment
• T4 - 10 to 15 ug/kg/ day• Dose adjusted by close monitoring of TSH
levels• T4 requirements- relatively great during first
year of life• High circulating T4 level is usually needed to
normalize TSH• Early treatment with T4 results in normal IQ
levels
![Page 33: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/33.jpg)
Hyperthyroidism
• Excessive thyroid function
Thyrotoxicosis• State of thyroid hormone excess
Major etiologies of thyrotoxicosis• Hyperthyroidism caused by Graves' disease• Toxic multinodular goiter• Toxic adenomas
![Page 34: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/34.jpg)
TreatmentHyperthyroidism of Graves' disease is treated by reducing
thyroid hormone synthesis• Antithyroid drugs• Reducing the amount of thyroid tissue with radioiodine (131I)• Subtotal thyroidectomy
No single approach is optimal and that patients may require multiple treatments to achieve remission.
Antithyroid drugs are the predominant therapy in many centers in Europe and Japan
Radioiodine is more often the first line of treatment in North America
![Page 35: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/35.jpg)
ANTITHYROID DRUGS (Drugs used in hyperthyroidism)
• Thioamides (reduce the synthesis of thyroid hoemones)
– Carbimazole– Methimazole– Propylthiouraciliodide
• Radioactive iodine (I131)• Iodide ( high doses) • Ionic inhibitors (inhibit iodide uptake) - use is obsolete due to toxicity
– Thiocyanates– Perchlorates– Nitrates
• Propranolol - Adjunct therapy in thyrotoxicosis
![Page 36: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/36.jpg)
Thioamides• Mechanism
– reduce the synthesis of thyroid hormones by inhibiting iodination of tyrosine and coupling of iodotyrosine to form T3 and T4
• Clinical use– Carbimazole
• Graves disease-till remission of symptoms (30-60mg) maintenance dose(5-15mg)
– Propylthiouracil (300-450 mg/d orally) maintenance dose (50-150 mg/d)
• Nodular toxic goiter• Prior to surgery for hyperthyroidism• With radioactive iodine to decrease symptoms before
radiation effects are manifested• Adverse effects
– Hypothyroidism– Vasculitis, agranulocytosis, Hypoprothrombinaemia– Cholestatic jaundice – Hair pigmentation
![Page 37: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/37.jpg)
Iodides
• Mechanism – Selectively trapped by the thyroid gland (uptake being
increased in hyperthyroidism and reduced in hypothyroidism).– Large doses inhibit secretion of thyroid hormones by inhibition
of thyroglobulin proteolysis– Induce involution and decrease vascularity of the gland.
• Clinical use• Preoperative use in thyroid surgery(Potassium iodide, 60
mg orally thrice daily) • Thyroid crisis • Accidental over dosage of radioactive iodine (to protect
the thyroid follicles)• Prophylactic use in endemic goiter. Added to salt (1 in
100,000 parts )as iodized salts.• As an expectorant, antiseptic for topical use
![Page 38: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/38.jpg)
Adverse effects- Thioamides
• maculpapular pruritic rash • murticarial rash• Arthralgia• Lymphadenopathy• lupus-like syndrome• Polyserositis
![Page 39: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/39.jpg)
• Adverse reactions
– Acute hypersensitivity reactions (angioneurotic oedema, skin haemorrage, drug fever)
– salivation, lacrimation, soreness of throat, conjunctivitis, coryza-like symptoms, skin rashes
– Foetal or neonatal goiter
![Page 40: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/40.jpg)
Radiioactive iodine
• Mechanism of action
– Trapped by the thyroid follicles and incorporated into thyroglobulin
– Emits both beta and gamma rays(half-life 8 days)
– Beta rays - short range and act on thyroid tissue only
– The gamma rays are more penetrative and can be detected by Gieger counter for diagnostic use.
![Page 41: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/41.jpg)
Clinical Use
• Radioactive sodium iodide (5-8 m curie) orally.
• Grave’s disease, including relapse after subtotal thyroidectomy.
• Toxic nodular goiter
• Thyroid carcinoma
• Diagnosis of thyroid function . 50-100 micro curie is administered.
• best in patients over 35 years and in the presence of cardiac disease
• Clinical response is slow and may take 6-12 weeks for suppression of hyperthyroid symdrome
![Page 42: Thyroid pharmacology](https://reader033.vdocument.in/reader033/viewer/2022061603/5681433e550346895dafb30c/html5/thumbnails/42.jpg)
Effects of drugs on thyroid functions Drugs. Effect
Dopamine, l-dopa, corticosteroids, somatostatin
Inhibition of TRH and TSH secretion.
Iodides, lithium. Inhibition of thyroxine synthesis, and hypothyroidism
Cholestyramine, colestipol, sucralfate, aluminium salts
Inhibit thyroxine absorption from gut
Phenytoin, carbamazepine, rifampicin, phenobarbitone
Enzyme induction. May enhance T3 and T4 metabolism
Propylthiouracil, amiodarone Inhibit conversion of T4 to T3
corticosteroids, beta-blockers Androgens, glucocorticoids,
Decrease thyroxine-binding globulin
Oestrogens, tamoxifen, mitotane Increase thyroxine-binding globulin
Salicylates, mefenamic acid, furosemide
Displace T3 and T4 from thyroxine –binding globulin.